Compounds and compositions for modulating EGFR Activity
US9440957B2 · kind B2 · utility
2Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2013 |
| Grant date | Sep 13, 2016 |
| Priority date | — |
| Expiry date | Jun 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating EGFR activity, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated EGFR activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.